HUP9902119A3 - Diphenyl stilbene derivatives as cox-2 inhibitors and pharmaceutical compositions of the same - Google Patents

Diphenyl stilbene derivatives as cox-2 inhibitors and pharmaceutical compositions of the same

Info

Publication number
HUP9902119A3
HUP9902119A3 HU9902119A HUP9902119A HUP9902119A3 HU P9902119 A3 HUP9902119 A3 HU P9902119A3 HU 9902119 A HU9902119 A HU 9902119A HU P9902119 A HUP9902119 A HU P9902119A HU P9902119 A3 HUP9902119 A3 HU P9902119A3
Authority
HU
Hungary
Prior art keywords
cox
inhibitors
same
pharmaceutical compositions
stilbene derivatives
Prior art date
Application number
HU9902119A
Other languages
English (en)
Original Assignee
Merck Frosst Canada & Co Kirkl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605647.8A external-priority patent/GB9605647D0/en
Application filed by Merck Frosst Canada & Co Kirkl filed Critical Merck Frosst Canada & Co Kirkl
Publication of HUP9902119A2 publication Critical patent/HUP9902119A2/hu
Publication of HUP9902119A3 publication Critical patent/HUP9902119A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/16Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/24Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pyridine Compounds (AREA)
HU9902119A 1996-02-01 1997-01-29 Diphenyl stilbene derivatives as cox-2 inhibitors and pharmaceutical compositions of the same HUP9902119A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1095096P 1996-02-01 1996-02-01
GBGB9605647.8A GB9605647D0 (en) 1996-03-18 1996-03-18 Diphenyl stilbenes as prodrugs to cox-2 inhibitors
PCT/CA1997/000063 WO1997028120A1 (en) 1996-02-01 1997-01-29 Diphenyl stilbenes as prodrugs to cox-2 inhibitors

Publications (2)

Publication Number Publication Date
HUP9902119A2 HUP9902119A2 (hu) 2001-04-28
HUP9902119A3 true HUP9902119A3 (en) 2001-08-28

Family

ID=26308949

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9902119A HUP9902119A3 (en) 1996-02-01 1997-01-29 Diphenyl stilbene derivatives as cox-2 inhibitors and pharmaceutical compositions of the same

Country Status (19)

Country Link
EP (1) EP0882015B1 (hu)
JP (1) JP3662936B2 (hu)
KR (1) KR19990082260A (hu)
CN (1) CN1214677A (hu)
AT (1) ATE198323T1 (hu)
AU (1) AU707199B2 (hu)
CA (1) CA2244134C (hu)
CZ (1) CZ241698A3 (hu)
DE (1) DE69703791T2 (hu)
EA (1) EA199800675A1 (hu)
EE (1) EE9800230A (hu)
ES (1) ES2152648T3 (hu)
HU (1) HUP9902119A3 (hu)
IL (1) IL125441A0 (hu)
NO (1) NO983511L (hu)
NZ (1) NZ326283A (hu)
PL (1) PL328225A1 (hu)
SK (1) SK102698A3 (hu)
WO (1) WO1997028120A1 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635417B1 (en) 1996-07-31 2003-10-21 California Institute Of Technology Complex formation between DSDNA and oligomer of cyclic heterocycles
US5998140A (en) * 1996-07-31 1999-12-07 The Scripps Research Institute Complex formation between dsDNA and oligomer of cyclic heterocycles
JP2003523958A (ja) 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−2の阻害剤、組成物ならびに使用法
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
WO2004011421A1 (en) * 2002-07-26 2004-02-05 Merck Frosst Canada & Co. Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
EP1542972A4 (en) 2002-07-29 2008-01-23 Nitromed Inc CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITION AND METHOD OF USE
ATE432258T1 (de) 2003-03-05 2009-06-15 Merck Frosst Company Stickstoffmonoxid freisetzende prodrugs von diaryl-2-(5h)-furanonen als inhibitoren von cyclooxygenase-2
JP2007520483A (ja) 2004-01-27 2007-07-26 メルク フロスト カンパニー シクロオキシゲナーゼ−2インヒビターとしてのジアリール−2−(5h)−フラノンの一酸化窒素放出プロドラッグ
US7622502B2 (en) 2004-01-27 2009-11-24 Merck Frosst Canada & Co. Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
WO2006029436A1 (de) * 2004-09-17 2006-03-23 Universität Wien Cox-ii-inhibitorverbindungen
CA3209491A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082974A (en) * 1989-04-24 1992-01-21 Otsuka Pharaceutical Factory, Inc. 3-halogeno-2,3-diphenylacrylaldehyde derivatives, process for preparing the same and a pharmaceutical composition for treating hyperlipidemi
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5393790A (en) * 1994-02-10 1995-02-28 G.D. Searle & Co. Substituted spiro compounds for the treatment of inflammation

Also Published As

Publication number Publication date
DE69703791D1 (de) 2001-02-01
EP0882015B1 (en) 2000-12-27
ATE198323T1 (de) 2001-01-15
CA2244134C (en) 2005-04-26
JP2000504332A (ja) 2000-04-11
EP0882015A1 (en) 1998-12-09
AU707199B2 (en) 1999-07-08
ES2152648T3 (es) 2001-02-01
PL328225A1 (en) 1999-01-18
NO983511L (no) 1998-09-30
AU1434697A (en) 1997-08-22
CA2244134A1 (en) 1997-08-07
KR19990082260A (ko) 1999-11-25
CZ241698A3 (cs) 1998-12-16
WO1997028120A1 (en) 1997-08-07
EA199800675A1 (ru) 1999-02-25
MX9806213A (es) 1998-12-31
DE69703791T2 (de) 2001-06-21
JP3662936B2 (ja) 2005-06-22
HUP9902119A2 (hu) 2001-04-28
SK102698A3 (en) 1999-04-13
NO983511D0 (no) 1998-07-30
EE9800230A (et) 1998-12-15
IL125441A0 (en) 1999-03-12
NZ326283A (en) 1998-12-23
CN1214677A (zh) 1999-04-21

Similar Documents

Publication Publication Date Title
HUP9702035A3 (en) Inhibitors of leukocita-adhesion- and vla-4-antagonists and pharmaceutical compositions containing them
HUP9702036A3 (en) Inhibitors of leucocita-adhesion and wla-4-antagonists and pharmaceutical compositions containing them
IL120141A0 (en) Substituted quinazoline derivatives and pharmaceutical compositions containing them
HUP9702034A3 (en) Inhibitors of leukocita-adhesion and vla-4-antagonists and pharmaceutical compositions containing them
BR1100403A (pt) Composto e composição farmacêutica de inibidores de cox-2
IL206621A0 (en) Caspase inhibitors and pharmaceutical compositions containing the same
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
HUP0000065A3 (en) Olanzapine dihydrate d and pharmaceutical compositions containing the same
IL140862A (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
IL135176A0 (en) Benzothiazole derivatives and pharmaceutical compositions containing the same
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
IL128664A (en) Heterocyclic metalloprotease inhibitors and pharmaceutical compositions comprising them
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
IL135177A0 (en) Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
HUP9900424A2 (hu) Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
IL116916A (en) Substituted biphenyl sulfonamide derivatives and pharmaceutical compositions containing the same
IL133097A0 (en) Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof
HUP0102646A3 (en) Phthalazine derivatives phosphodiesterase 4 inhibitors and pharmaceutical compositions containing the same
IL143802A0 (en) Imidazole derivatives and pharmaceutical compositions containing the same
IL141080A0 (en) Disubstituted maleimide derivatives and pharmaceutical compositions containing the same
HUP0103203A3 (en) Azaadamantane derivatives and pharmaceutical compositions thereof
IL138247A (en) Substituted bisindolymaleimides for the inhibition of cell proliferation and pharmaceutical compositions comprising them
HUP0004644A3 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase and pharmaceutical compositions containing them